Clinical Trials Directory

Trials / Unknown

UnknownNCT04738266

Unmasking the Prevalence of AC in an Unselected Echocardiographic Population

A National Survey of Prevalence and Accuracy of Echocardiographic Red Flags of Amyloid Cardiomyopathy in Consecutive Patients Undergoing Routine Echocardiography.

Status
Unknown
Phase
Study type
Observational
Enrollment
381 (actual)
Sponsor
University of Trieste · Academic / Other
Sex
All
Age
55 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the prevalence of echocardiographic red-flags of amyloid cardiomyopathy (AC) in patients undergoing clinically-indicated echocardiography (observational phase) and the prevalence of AC among AC-suggestive echocardiograms (interventional phase).

Detailed description

Prospective multicenter Italian survey consisting of two phases: observational (echocardiographic screening for amyloid cardiomyopathy among patients ≥ 55 years undergoing clinically-indicated echocardiography) and interventional (specific clinical and instrumental work-up to detect the prevalence of amyloid cardiomyopathy among amyloid cardiomyopathy-suggestive echocardiograms).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAmyloid CardiomyopathyEchocardiographic red flags of Amyloid Cardiomyopathy to guide the suspicion of disease and to proceed with second level diagnostic work up including cardiac scintigraphy with bone tracers and search of monoclonal component in serum and urine

Timeline

Start date
2020-11-20
Primary completion
2021-01-20
Completion
2021-07-25
First posted
2021-02-04
Last updated
2021-02-04

Locations

16 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT04738266. Inclusion in this directory is not an endorsement.